Exhibit 99.2
Versum Materials’ Board of Directors Rejects Unsolicited Tender Offer from Merck KGaA
Urges Stockholders Not to Tender Their Shares
Determines to Engage in Discussions with Merck
TEMPE, Ariz. – March 29, 2019 – Versum Materials, Inc. (NYSE: VSM) today announced that its board of directors (the “Versum Board”), after careful consideration and consultation with its financial and legal advisors, unanimously determined to reject the unsolicited tender offer from Merck KGaA (“Merck”) to acquire all outstanding shares of Versum for $48 per share in cash (the “Offer”). The Versum Board determined that the Offer is not in the best interests of Versum or its stockholders. Accordingly, the Versum Board recommends that Versum stockholders reject the Offer and not tender their shares into the Offer.
The reasons for the Versum Board’s recommendation to reject the Offer are set forth in aSchedule 14D-9, being filed by Versum with the Securities and Exchange Commission (“SEC”) today, which is also being disseminated to stockholders. Versum’sSchedule 14D-9 will also be available on the SEC’s website at www.sec.gov and on Versum’s website at www.versummaterials.com.
Versum also announced today that a meeting occurred between representatives of Versum and Merck pursuant to a limited waiver granted by Entegris, Inc. (NASDAQ: ENTG) under the previously announced merger agreement between Versum and Entegris. After consideration of such meeting, the Versum Board has determined, after consultation with its financial and legal advisors, that Merck’s proposal could reasonably be expected to result in a superior proposal under Versum’s merger agreement with Entegris and has authorized Versum’s management and its advisers to engage in further discussions with, and providenon-public information to, Merck.
The Versum Board has not changed its recommendation in support of the pendingall-stock merger of equals with Entegris.
Lazard and Citi are serving as financial advisors to Versum and Simpson Thacher & Bartlett LLP is serving as legal counsel.
About Versum Materials
Versum Materials, Inc. (NYSE: VSM) is a leading global specialty materials company providing high-purity chemicals and gases, delivery systems, services and materials expertise to meet the evolving needs of the global semiconductor and display industries. Derived from the Latin word for “toward,” the name “Versum” communicates the company’s deep commitment to helping customers move toward the future by collaborating, innovating and creating cutting-edge solutions.
A global leader in technology, quality, safety and reliability, Versum Materials is one of the world’s leading suppliers of next-generation CMP slurries, ultra-thin dielectric and metal film precursors, formulated cleans and etching products, and delivery equipment that has revolutionized the semiconductor industry. Versum Materials reported fiscal year 2018 annual sales of about U.S. $1.4 billion, has approximately 2,300 employees and operates 14 major facilities in Asia and the North America. It is headquartered in Tempe, Arizona. Versum Materials had operated for more than three decades as a division of Air Products and Chemicals, Inc. (NYSE:APD).
For additional information, please visithttp://www.versummaterials.com.
Additional Information About the Merck Tender Offer
Versum Materials, Inc. (“Versum Materials”) intends to file a solicitation/recommendation statement with respect to the tender offer with the SEC within 10 business days of the commencement of the tender offer.INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE SOLICITATION/RECOMMENDATION STATEMENT WITH